Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

WITHDRAWN: Haemostatic drugs for traumatic brain injury.

Perel P, Roberts I, Shakur H, Thinkhamrop B, Phuenpathom N, Yutthakasemsunt S.

Cochrane Database Syst Rev. 2015 May 13;5:CD007877. [Epub ahead of print]

PMID:
25970597
2.

Antifibrinolytic drugs for acute traumatic injury.

Ker K, Roberts I, Shakur H, Coats TJ.

Cochrane Database Syst Rev. 2015 May 9;5:CD004896. [Epub ahead of print]

PMID:
25956410
3.

Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.

Ker K, Tansley G, Beecher D, Perner A, Shakur H, Harris T, Roberts I.

Cochrane Database Syst Rev. 2015 Feb 26;2:CD011386. doi: 10.1002/14651858.CD011386.pub2.

PMID:
25914907
4.

Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.

Ker K, Tansley G, Beecher D, Perner A, Shakur H, Harris T, Roberts I.

Cochrane Database Syst Rev. 2015 Feb 26;2:CD011386. doi: 10.1002/14651858.CD011386.pub2.

PMID:
25714073
5.

Good clinical practice in trauma care research: considerations for inter-hospital patient transfers.

Bryceland C, Ellis S, Beaumont D, Shakur H, Coats TJ.

Int Emerg Nurs. 2015 Jan;23(1):42-4. No abstract available.

PMID:
25692201
6.

HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial.

Roberts I, Coats T, Edwards P, Gilmore I, Jairath V, Ker K, Manno D, Shakur H, Stanworth S, Veitch A.

Trials. 2014 Nov 19;15:450. doi: 10.1186/1745-6215-15-450.

7.

Guide to the design and review of emergency research when it is proposed that consent and consultation be waived.

Davies H, Shakur H, Padkin A, Roberts I, Slowther AM, Perkins GD.

Emerg Med J. 2014 Oct;31(10):794-5. doi: 10.1136/emermed-2014-203675. Epub 2014 Jul 31. No abstract available.

PMID:
25082718
8.

Treatment for primary postpartum haemorrhage.

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Cochrane Database Syst Rev. 2014 Feb 13;2:CD003249. doi: 10.1002/14651858.CD003249.pub3. Review.

PMID:
24523225
9.

Central and statistical data monitoring in the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial.

Edwards P, Shakur H, Barnetson L, Prieto D, Evans S, Roberts I.

Clin Trials. 2013 Dec 17;11(3):336-343. [Epub ahead of print]

PMID:
24346610
10.

Tranexamic acid in trauma: we need stronger global health policy.

Alvarado JC, Dewan Y, Elsayed HF, Gogichaishvili T, Gupta S, Hunt BJ, Iribhogbe P, Izurieta M, Khamis H, Komolafe EO, Mantilla JH, Miranda J, Uribe CH, Olaomi O, Olldashi F, Perel P, Ramana PV, Ravi RR, Roberts I, Shakur H.

BMJ. 2013 Jul 23;347:f4593. doi: 10.1136/bmj.f4593. No abstract available.

PMID:
23881931
12.

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Health Technol Assess. 2013 Mar;17(10):1-79. doi: 10.3310/hta17100.

13.

Antifibrinolytic drugs for acute traumatic injury.

Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators.

Cochrane Database Syst Rev. 2012;12:CD004896. Review.

PMID:
23418644
14.

A promise to save 100,000 trauma patients.

Shakur H, Roberts I, Piot P, Horton R, Krug E, Mersch J.

Lancet. 2012 Dec 15;380(9859):2062-3. doi: 10.1016/S0140-6736(12)62037-6. No abstract available.

PMID:
23245601
15.

Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.

Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, Lecky F, Brohi K, Willett K; CRASH-2 Collaborators.

BMJ. 2012 Sep 11;345:e5839. doi: 10.1136/bmj.e5839.

16.

Predicting early death in patients with traumatic bleeding: development and validation of prognostic model.

Perel P, Prieto-Merino D, Shakur H, Clayton T, Lecky F, Bouamra O, Russell R, Faulkner M, Steyerberg EW, Roberts I.

BMJ. 2012 Aug 15;345:e5166. doi: 10.1136/bmj.e5166.

17.

CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial.

Dewan Y, Komolafe EO, Mejía-Mantilla JH, Perel P, Roberts I, Shakur H; CRASH-3 Collaborators.

Trials. 2012 Jun 21;13:87. doi: 10.1186/1745-6215-13-87.

18.

Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.

Ker K, Edwards P, Perel P, Shakur H, Roberts I.

BMJ. 2012 May 17;344:e3054. doi: 10.1136/bmj.e3054. Review.

19.

CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.

Perel P, Al-Shahi Salman R, Kawahara T, Morris Z, Prieto-Merino D, Roberts I, Sandercock P, Shakur H, Wardlaw J.

Health Technol Assess. 2012;16(13):iii-xii, 1-54. doi: 10.3310/hta16130.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk